Pancreatic Cysts Increase Cancer Risk

Patients with pancreatic cysts are more likely to develop pancreatic cancer within one or two years of the cyst diagnosis. Surgical removal of such cyst helps prevent cancer.

Patients with pancreatic cysts have a significantly higher overall risk of pancreatic cancer compared to those without such cysts, according to a new study.

Certain types of pancreatic cysts (such as mucinous neoplasms) are known to have malignant potential based on their form or structure. Surveillance (watching) or surgical resection (removal) are possible ways to manage these.

Enzyme Linked to Aggressive Pancreatic Cancer Offers Potential Clinical Advances
An enzyme is being discovered by Mayo Clinic researchers which they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

‘The overall risk of developing pancreatic cancer was estimated to be 19.64 times greater in patients with pancreatic cysts.’

But other types of cysts do not fit the "potentially malignant" profile at the time they are detected (described as "morphologically benign"). Because previous studies did not follow patients for more than two years, experts have not known what the overall long-term risk is for developing pancreatic cancer in patients with cysts.

The study, "Risk of pancreatic cancer in patients with pancreatic cyst," looked at the history of patients in the Veterans Health Administration database, examining all patient encounters from October 1998 through September 2007.

They included 520,970 patients, 755 of whom were diagnosed with pancreatic cysts. The study did not differentiate between different types of pancreatic cysts. After adjusting for age, race, smoking and alcohol use, which are independent risk factors for pancreatic cancer, the researchers followed the history of patients with and without pancreatic cysts from the time of cyst diagnosis to the time of cancer diagnosis.

New Molecule may Determine How Aggressive Pancreatic Cancer Will be in a Patient
An enzyme has been discovered by a team of researchers and it is believed that it is linked to how aggressive pancreatic cancer may be for a patient

Those who did not develop cancer were followed until the end of the study or until they were lost to follow-up. In the group with cysts, 17 of the 775 patients were diagnosed with pancreatic cancer over the time period of the study.

Of those, five were diagnosed with cancer within one to two years of the cyst diagnosis; six patients within two to four years; and three within four to six years. The remaining three patients were diagnosed with pancreatic cancer within six to eight years of their cyst diagnosis.

Pancreatic Cancer Study Discovers New Genetic Risk Markers
A new discovery has been made with the help of large DNA analysis of humans, which says that there are several genetic markers to spot pancreatic cancer.

In the large group of patients without cysts, 1,206 out of 520,415 were eventually diagnosed with pancreatic cancer. The mean age of patients diagnosed across both groups was 62 years, 11.5 months.

The overall risk of pancreatic cancer was estimated to be 19.64 times greater in the group with pancreatic cysts. Pancreatic cysts that have not produced symptoms are being detected more frequently in patients as a result of increased use and improved quality of abdominal imaging ordered for various reasons.

Use of Low-dose Aspirin may Reduce Pancreatic Cancer Risk
The use of low dose aspirin may actually help an individual reduce his risk of developing pancreatic cancer, a new study has found

Prevalence of pancreatic cysts as an incidental finding on magnetic resonance imaging (MRI) was reported to range from 2.4 percent to 19.6 percent in two studies from 2010. Surgery is performed in only a small fraction of patients with pancreatic cysts.

The authors noted the need for future studies to evaluate the risk of pancreatic cancer in patients with documented mucinous cysts, based on cyst size and patient age, to help create appropriate strategies for diagnostic evaluation and management.

The study is published in the GIE: Gastrointestinal Endoscopy, the journal of the American Society for Gastrointestinal Endoscopy (ASGE).

Source-Eurekalert